PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Minimally invasive coronary calcium CT scans used to determine heart disease risk are effective at finding other potential health problems

2025-11-08
(Press-News.org) Coronary artery calcium (CAC) CT scans are becoming a more commonly used tool to effectively determine a patient’s future risk of heart disease and heart attack.  

These minimally invasive scans measure how much calcium is already present in the arteries of the heart, so that clinicians can determine if a patient needs medical intervention or other preventative measures, including statin medications.

Now an important new study from heart researchers at Intermountain Health in Salt Lake City finds that routine coronary artery calcium CT scans are also proving to be effective in uncovering other medical issues in patients, some of them life-threatening.

“In nearly one in 10 of these kinds of heart scans, we’re finding other possible medical issues,” said Brent Muhlestein, MD, co-director of research at Intermountain Medical Center. “They could be nothing, as many abnormalities on these kinds of scans are. But they could be something more significant, as was the case for one study participant who had emergency surgery due to a finding on his CAC CT scan.” 

The findings are part of the Intermountain CorCal clinical trial, which randomized asymptomatic, otherwise healthy patients to have their risk of developing plaque buildup in their arteries in one of two ways: either through current treatment standards or a CAC CT scan. 

Of the 2,284 patients in the Intermountain study who received CAC CT scans, radiologists found other potentially significant medical findings in 247 – or 8.5% – of patients.

More than half of these findings were lung abnormalities, but issues were also found in just about every organ included in the CT scan area, including esophagus, liver, kidney, breast, bone and other parts of the heart.

“These results show that proactive cardiac CT scans may be useful to identify other health issues for patients, beyond cardiac calcium levels,” said Dr. Muhlestein.

Findings from the study were presented at the American Heart Association Scientific Sessions 2025 in in New Orleans.

Of those 247 patients, two thirds were referred for follow up care. Of that group, 23 patients were found to have thoracic aortic aneurysms, which are bulges in the part of the aorta in the chest, larger than 4.5 centimeters. 

One of these patients was eight centimeters, which is considered an emergency.

“That patient went into surgery within a week of us finding it,” Dr. Muhlestein said. “We’re confident in saying we’ve saved at least one life through this study and that this tool may be useful in other preventive ways.” 

Previous research from the Intermountain CorCal study has already shown that CAC CT scans may be effective as a way of determining which patients might benefit from  statin medication to protect their heart health. 

Whether it’s worth the time and expense to expand the work of radiologists reading these scans has yet to be determined, said Dr. Muhlestein.

“These findings don’t show if every patient who was recommended for follow up care needed it. But the findings from our study are significant enough that it’s worth asking that question. We’ll continue to explore these findings as a preventive health tool,” he said.

                                                                          ###

END


ELSE PRESS RELEASES FROM THIS DATE:

High-impact clinical trials generate promising results for improving kidney health - part 3

2025-11-08
Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce albuminuria (excess albumin in the urine) and the risk of chronic kidney disease (CKD) progression, and certain mineralocorticoid receptor antagonists have similar effects in people with type 2 diabetes and CKD. Investigators recently assessed the albuminuria-lowering efficacy and safety of the novel mineralocorticoid receptor antagonist balcinrenone combined with the SGLT2 dapagliflozin. In the double-blind, active-controlled clinical trial, both doses of this novel balcinrenone/dapagliflozin combination outperformed dapagliflozin alone, cutting levels of ...

Mass General Brigham researchers find PCSK9 inhibitor reduced risk of first heart attack, stroke

2025-11-08
Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients’ treatment significantly reduced the risk of major adverse cardiovascular events in those who are at high risk. Results were presented today at the American Heart Association Scientific Sessions and simultaneously published in The New England Journal of Medicine.   “The results of this trial offer hope for preventing a first heart attack, stroke, or other ...

Triglyceride-lowering drug significantly reduced rate of acute pancreatitis in high-risk patients

2025-11-08
Researchers from Mass General Brigham have found that olezarsen—a drug designed to lower triglyceride levels—can also decrease the risk of acute pancreatitis, a potential complication in patients with severely elevated triglyceride levels. The results, from two randomized, placebo-controlled trials (CORE-TIMI 72a and CORE2-TIMI 72b), were presented at the American Heart Association Scientific Sessions and simultaneously published in The New England Journal of Medicine. Severe hypertriglyceridemia is a condition in which the level of triglycerides (a type of fat that circulates in the blood) is very high. Approximately 1 in 100 people in the U.S. have severe hypertriglyceridemia. ...

Steatotic liver disease and cancer: From pathogenesis to therapeutic frontiers

2025-11-08
Steatotic liver disease (SLD), mainly encompassing metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic dysfunction and ALD (MetALD), has emerged as the dominant cause of chronic liver disease worldwide, displacing viral hepatitis as the primary aetiology. Globally, the prevalence of MASLD is estimated even over 30%, affecting over one-third of adults. Parallelly, alcohol remains a major risk factor, with heavy drinking contributing to 90–95% of SLD cases and up to 10% advancing to cancer.   Genetic ...

SGLT2 inhibitors and kidney outcomes by glomerular filtration rate and albuminuria

2025-11-08
About The Study: The findings of this study support the routine use of sodium-glucose cotransporter 2 (SGLT2) inhibitors to improve kidney outcomes across the full spectrum of kidney function and albuminuria among patients with type 2 diabetes, chronic kidney disease, or heart failure.  Corresponding Authors: To contact the corresponding authors, email Brendon L. Neuen, PhD (bneuen@georgeinstitute.org.au) and Hiddo J. L. Heerspink, PhD (h.j.lambers.heerspink@umcg.nl). To access the embargoed study: Visit our For The ...

Comprehensive analysis supports routine use of metabolic drug for people with all levels of kidney function

2025-11-08
In late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two companion papers in JAMA, the findings are based on data from over 70,000 participants across 10 major randomised controlled trials.  The meta-analyses were conducted by the SGLT2 Inhibitor Meta-analysis Cardio-Renal Trialists’ Consortium (SMART-C), led by The George Institute for Global Health. SGLT2 inhibitors, originally developed to treat type 2 diabetes, have since demonstrated substantial protection against heart failure and chronic ...

Temporary benefit for immune system in early HIV treatment, but dysregulation returns

2025-11-08
Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at Amsterdam UMC investigated whether this dysregulation can be prevented by starting HIV medication immediately after infection – i.e. within a few days. They saw that six months after this early treatment, the immune system did indeed work as in people without HIV. But in the longer term, the immune system was disrupted again. This is shown by research by Amsterdam UMC, published in the journal EBioMedicine. Early treatment protects immune systems only temporarily For this study, the scientists examined ...

Chronic kidney disease is now the ninth leading cause of death

2025-11-08
Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose from 378 million people with the disease in 1990 to 788 million in 2023 as the world population grew and aged, making it for the first time a top 10 cause of death worldwide.   Led by researchers at NYU Langone Health, the University of Glasgow, and the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, the analysis explored the rise of the illness, in which the kidneys gradually lose their ability to filter waste and excess fluid from the blood. Mild cases may have no symptoms while the most severe stages ...

Chronic kidney disease has more than doubled since 1990, now affecting nearly 800 million people worldwide

2025-11-08
In 2023, chronic kidney disease (CKD) was the 9th-leading cause of death worldwide, responsible for nearly 1.5 million deaths. Unlike most other leading causes of death, CKD mortality rates continue to rise, signaling a growing global health crisis.  In 2023, CKD ranked as the 12th-leading cause of disability worldwide and the 7th-leading driver of cardiovascular deaths. Kidney dysfunction alone accounted for almost 12% of all global cardiovascular deaths. Diabetes, obesity, and high blood pressure remain the top drivers of CKD, alongside dietary risks and environmental factors.  SEATTLE, Wash. – Nov. 7, ...

Participant experiences in a kidney failure care intervention in the navigate-kidney study

2025-11-08
About The Study: The results of this study suggest that community health workers played a vital role in improving patient engagement, emotional wellbeing, and self-efficacy, suggesting their integration into dialysis care teams may enhance holistic, patient-centered care.  Corresponding Author: To contact the corresponding author, Lilia Cervantes, MD, email Lilia.Cervantes@cuanschutz.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2025.48506) Editor’s ...

LAST 30 PRESS RELEASES:

Coronary artery calcium may be a predictor for all-cause mortality, including medical conditions not related to heart health

Minimally invasive coronary calcium CT scans used to determine heart disease risk are effective at finding other potential health problems

High-impact clinical trials generate promising results for improving kidney health - part 3

Mass General Brigham researchers find PCSK9 inhibitor reduced risk of first heart attack, stroke

Triglyceride-lowering drug significantly reduced rate of acute pancreatitis in high-risk patients

Steatotic liver disease and cancer: From pathogenesis to therapeutic frontiers

SGLT2 inhibitors and kidney outcomes by glomerular filtration rate and albuminuria

Comprehensive analysis supports routine use of metabolic drug for people with all levels of kidney function

Temporary benefit for immune system in early HIV treatment, but dysregulation returns

Chronic kidney disease is now the ninth leading cause of death

Chronic kidney disease has more than doubled since 1990, now affecting nearly 800 million people worldwide

Participant experiences in a kidney failure care intervention in the navigate-kidney study

Community health worker support for Hispanic and Latino individuals receiving hemodialysis

Scientists unveil new strategies to balance farming and ecological protection in Northeast China

UT Health San Antonio scientist helps shape new traumatic brain injury guidelines

Rising nitrogen and rainfall could supercharge greenhouse gas emissions from the world’s largest grasslands

Study uncovers glomerular disease outcomes across the lifespan

Sotagliflozin outperforms dapagliflozin for reducing salt- sensitive hypertension and kidney injury in rats

Trial analysis reveals almost all adults with hypertensive chronic kidney disease would benefit from intensive blood pressure lowering

A husband’s self-esteem may protect against preterm births, study finds

Michigan State University's James Madison College receives over $1 million to launch civic education academy

White paper on recovering from burnout through mentoring released by University of Phoenix College of Doctoral Studies

Defunct Pennsylvania oil and gas wells may leak methane, metals into water

Kessler Foundation’s John DeLuca, PhD, honored with Reitan Clinical Excellence Award from National Academy of Neuropsychology

Discordance in creatinine- and cystatin C–based eGFR and clinical outcomes

Disagreement between two kidney function tests predicts serious health problems

American College of Cardiology, OpenEvidence to advance AI-enabled, evidence-based cardiovascular care

OHSU researchers develop promising drug for aggressive breast cancer

Evaluating the potential of a sleep intervention among youth at high-risk for borderline personality disorder

Saturn’s icy moon may host a stable ocean fit for life, study finds

[Press-News.org] Minimally invasive coronary calcium CT scans used to determine heart disease risk are effective at finding other potential health problems